Fulgent Genetics (FLGT) Income towards Parent Company (2015 - 2026)

Fulgent Genetics has reported Income towards Parent Company for 11 years, with the latest figure at -$29.7 million in Q2 2026.

• Quarterly Income towards Parent Company fell 54.64% year-over-year to -$29.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$79.2 million (down 52.12% YoY) and the FY2025 annual result came in at -$55.3 million, down 26.24% from the prior year.
• Income towards Parent Company retreated to -$29.7 million in Q2 2026 per FLGT's latest filing, from -$25.3 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $153.6 million in Q1 2022 and troughed at -$122.9 million in Q4 2023.
• A 5-year average of -$9.8 million and a median of -$13.7 million in 2023 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2023 and 2024: Income towards Parent Company plunged 1102.68% in 2023, then soared 94.95% in 2024.
• Over 5 years, Income towards Parent Company stood at -$24.1 million in 2022, then sank by 410.33% to -$122.9 million in 2023, then jumped by 94.95% to -$6.2 million in 2024, then slumped by 179.74% to -$17.4 million in 2025, then plunged by 71.11% to -$29.7 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$29.7 million, -$25.3 million, and -$17.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.